Akums Drugs & Pharmaceuticals Ltd.
•₹ 750-0.39%
2026-08-21
ABOUT
KEY POINTS
Revenue Breakup Mar 2026 • CDMO: 80.1% • Branded & Generic Formulations: 12.7% • API: 5.0% • Trade Generics: 2.2%
PROS
- Company is almost debt free
- Latest quarter profit grew 56.1% YoY, showing strong momentum
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 3.57x)
- Company generates healthy free cash flow
- Institutional investors have been accumulating - FII+DII up 2.3pp
CONS
- Recent results are weak - TTM profit is down 31.7% versus prior year
- A large part of profit comes from other income (33.7% of PBT)
- Promoter holding has decreased over last 2 years: -9.6pp
- Company has a low return on equity of 8.8% over last 3 years
- Company has a low return on capital employed of 11.0%
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | AKUMS | 752.40 | 40.59 | 11842.32 | 0.40 | 100.98 | 56.11 | 1166.63 | 13.93 | 14.77 | 14.97 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 970 | 1,181 | 1,083 | 944 | 1,019 | 1,033 | 1,010 | 1,056 | 1,024 | 1,018 | 1,160 | 1,158 | 1,167 | |
| 1,095 | 1,029 | 989 | 941 | 891 | 912 | 889 | 962 | 895 | 923 | 1,013 | 1,006 | 1,058 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 8 | 7 | 9 | 10 | 7 | 13 | 15 | 18 | 27 | 32 | 34 | 35 | 30 |
| Interest | 12 | 14 | 12 | 12 | 13 | 12 | 5 | 5 | 23 | 23 | 24 | 24 | 25 |
| Depreciation | 30 | 30 | 32 | 34 | 34 | 35 | 45 | 40 | 37 | 38 | 40 | 40 | 41 |
| -159 | 87 | 59 | -33 | 87 | 92 | 91 | 75 | 96 | 66 | 100 | 121 | 139 | |
| Tax % | -18.03% | 62.48% | -228.95% | -20.04% | 30.03% | 27.23% | 27.17% | -99.11% | 32.37% | 34.99% | 32.03% | 32.89% | 27.48% |
| Net Profit | 0 | 0 | 0 | 0 | 61 | 67 | 66 | 150 | 65 | 43 | 68 | 81 | 101 |
| -13 | 2 | 13 | -3 | 4 | 4 | 4 | 10 | 4 | 3 | 4 | 6 | 1 | |
| Equity Capital | 29 | 29 | 29 | 29 | 29 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 29 | 29 | 29 | 29 | 29 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 970
- 1,095
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 12
- Depreciation
- 30
- -159
- Tax %
- -18.03%
- Net Profit
- 0
- -13
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 1,181
- 1,029
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 14
- Depreciation
- 30
- 87
- Tax %
- 62.48%
- Net Profit
- 0
- 2
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 1,083
- 989
- Operating Profit
- —
- OPM %
- —
- Other Income
- 9
- Interest
- 12
- Depreciation
- 32
- 59
- Tax %
- -228.95%
- Net Profit
- 0
- 13
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 944
- 941
- Operating Profit
- —
- OPM %
- —
- Other Income
- 10
- Interest
- 12
- Depreciation
- 34
- -33
- Tax %
- -20.04%
- Net Profit
- 0
- -3
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 1,019
- 891
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 13
- Depreciation
- 34
- 87
- Tax %
- 30.03%
- Net Profit
- 61
- 4
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 1,033
- 912
- Operating Profit
- —
- OPM %
- —
- Other Income
- 13
- Interest
- 12
- Depreciation
- 35
- 92
- Tax %
- 27.23%
- Net Profit
- 67
- 4
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 1,010
- 889
- Operating Profit
- —
- OPM %
- —
- Other Income
- 15
- Interest
- 5
- Depreciation
- 45
- 91
- Tax %
- 27.17%
- Net Profit
- 66
- 4
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 1,056
- 962
- Operating Profit
- —
- OPM %
- —
- Other Income
- 18
- Interest
- 5
- Depreciation
- 40
- 75
- Tax %
- -99.11%
- Net Profit
- 150
- 10
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 1,024
- 895
- Operating Profit
- —
- OPM %
- —
- Other Income
- 27
- Interest
- 23
- Depreciation
- 37
- 96
- Tax %
- 32.37%
- Net Profit
- 65
- 4
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 1,018
- 923
- Operating Profit
- —
- OPM %
- —
- Other Income
- 32
- Interest
- 23
- Depreciation
- 38
- 66
- Tax %
- 34.99%
- Net Profit
- 43
- 3
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 1,160
- 1,013
- Operating Profit
- —
- OPM %
- —
- Other Income
- 34
- Interest
- 24
- Depreciation
- 40
- 100
- Tax %
- 32.03%
- Net Profit
- 68
- 4
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 1,158
- 1,006
- Operating Profit
- —
- OPM %
- —
- Other Income
- 35
- Interest
- 24
- Depreciation
- 40
- 121
- Tax %
- 32.89%
- Net Profit
- 81
- 6
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 1,167
- 1,058
- Operating Profit
- —
- OPM %
- —
- Other Income
- 30
- Interest
- 25
- Depreciation
- 41
- 139
- Tax %
- 27.48%
- Net Profit
- 101
- 1
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,857 | 1,552 | 2,008 | 2,414 | 2,723 | 3,672 | 3,655 | 4,178 | 4,118 | 4,359 | 4,502 | |
| 1,663 | 1,353 | 1,826 | 2,240 | 2,431 | 3,764 | 3,361 | 4,055 | 3,658 | 3,837 | 4,000 | |
| Operating Profit | 204 | 214 | 204 | 202 | 312 | -69 | 384 | 157 | 517 | 651 | — |
| OPM % | 11 | 14 | 10 | 8 | 11 | -2 | 11 | 4 | 13 | 15 | — |
| Other Income | 9 | 15 | 22 | 27 | 21 | 23 | 90 | 34 | 56 | 129 | 132 |
| Interest | 16 | 13 | 23 | 20 | 7 | 17 | 46 | 51 | 35 | 94 | 96 |
| Depreciation | 46 | 52 | 56 | 67 | 70 | 95 | 113 | 126 | 153 | 155 | 159 |
| 143 | 150 | 126 | 114 | 172 | -193 | 150 | -45 | 345 | 382 | 426 | |
| Tax % | 33 | 40 | 46 | 62 | 28 | -30 | 35 | 102 | 0 | 33 | 31 |
| Net Profit | 96 | 90 | 68 | 44 | 123 | -251 | 98 | 1 | 344 | 256 | 293 |
| EPS | 813 | 777 | 579 | 357 | 17 | -18 | 7 | -0 | 22 | 17 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18 | — |
| Minority Interest | 0 | 0 | 0 | 4 | -1 | -2 | -3 | -5 | -6 | -1 | 1 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 7 | 7 | 5 | 3 | 9 | -18 | 7 | -0 | 22 | 17 | — |
| Minority Interest | 0 | 0 | 0 | 4 | -1 | -2 | -3 | -5 | -6 | -1 | 1 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 7 | 7 | 5 | 3 | 9 | -18 | 7 | -0 | 22 | 17 | — |
Mar 2017
- 1,857
- 1,663
- Operating Profit
- 204
- OPM %
- 11
- Other Income
- 9
- Interest
- 16
- Depreciation
- 46
- 143
- Tax %
- 33
- Net Profit
- 96
- EPS
- 813
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2018
- 1,552
- 1,353
- Operating Profit
- 214
- OPM %
- 14
- Other Income
- 15
- Interest
- 13
- Depreciation
- 52
- 150
- Tax %
- 40
- Net Profit
- 90
- EPS
- 777
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2019
- 2,008
- 1,826
- Operating Profit
- 204
- OPM %
- 10
- Other Income
- 22
- Interest
- 23
- Depreciation
- 56
- 126
- Tax %
- 46
- Net Profit
- 68
- EPS
- 579
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2020
- 2,414
- 2,240
- Operating Profit
- 202
- OPM %
- 8
- Other Income
- 27
- Interest
- 20
- Depreciation
- 67
- 114
- Tax %
- 62
- Net Profit
- 44
- EPS
- 357
- Dividend Payout %
- 0
- Minority Interest
- 4
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 4
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2021
- 2,723
- 2,431
- Operating Profit
- 312
- OPM %
- 11
- Other Income
- 21
- Interest
- 7
- Depreciation
- 70
- 172
- Tax %
- 28
- Net Profit
- 123
- EPS
- 17
- Dividend Payout %
- 0
- Minority Interest
- -1
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- -1
- Share of Associates
- 0
- Adjusted EPS
- 9
Mar 2022
- 3,672
- 3,764
- Operating Profit
- -69
- OPM %
- -2
- Other Income
- 23
- Interest
- 17
- Depreciation
- 95
- -193
- Tax %
- -30
- Net Profit
- -251
- EPS
- -18
- Dividend Payout %
- 0
- Minority Interest
- -2
- Share of Associates
- 0
- Adjusted EPS
- -18
- Minority Interest
- -2
- Share of Associates
- 0
- Adjusted EPS
- -18
Mar 2023
- 3,655
- 3,361
- Operating Profit
- 384
- OPM %
- 11
- Other Income
- 90
- Interest
- 46
- Depreciation
- 113
- 150
- Tax %
- 35
- Net Profit
- 98
- EPS
- 7
- Dividend Payout %
- 0
- Minority Interest
- -3
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- -3
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2024
- 4,178
- 4,055
- Operating Profit
- 157
- OPM %
- 4
- Other Income
- 34
- Interest
- 51
- Depreciation
- 126
- -45
- Tax %
- 102
- Net Profit
- 1
- EPS
- -0
- Dividend Payout %
- 0
- Minority Interest
- -5
- Share of Associates
- 0
- Adjusted EPS
- -0
- Minority Interest
- -5
- Share of Associates
- 0
- Adjusted EPS
- -0
Mar 2025
- 4,118
- 3,658
- Operating Profit
- 517
- OPM %
- 13
- Other Income
- 56
- Interest
- 35
- Depreciation
- 153
- 345
- Tax %
- 0
- Net Profit
- 344
- EPS
- 22
- Dividend Payout %
- 0
- Minority Interest
- -6
- Share of Associates
- 0
- Adjusted EPS
- 22
- Minority Interest
- -6
- Share of Associates
- 0
- Adjusted EPS
- 22
Mar 2026
- 4,359
- 3,837
- Operating Profit
- 651
- OPM %
- 15
- Other Income
- 129
- Interest
- 94
- Depreciation
- 155
- 382
- Tax %
- 33
- Net Profit
- 256
- EPS
- 17
- Dividend Payout %
- 18
- Minority Interest
- -1
- Share of Associates
- 0
- Adjusted EPS
- 17
- Minority Interest
- -1
- Share of Associates
- 0
- Adjusted EPS
- 17
TTM
- 4,502
- 4,000
- Operating Profit
- —
- OPM %
- —
- Other Income
- 132
- Interest
- 96
- Depreciation
- 159
- 426
- Tax %
- 31
- Net Profit
- 293
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 1
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 1
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 10%
- 5 Years:
- 10%
- 3 Years:
- 6%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 15%
- 5 Years:
- 16%
- 3 Years:
- 39%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- 57%
RETURN ON EQUITY
- 10 Years:
- 6%
- 5 Years:
- 2%
- 3 Years:
- 9%
- Last Year:
- 8%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 1 | 1 | 1 | 1 | 1 | 14 | 29 | 29 | 31 | 31 |
| 710 | 794 | 855 | 721 | 884 | 608 | 689 | 681 | 3,016 | 3,283 | |
| 183 | 143 | 182 | 165 | 96 | 345 | 421 | 368 | 14 | 73 | |
| Trade Payables | 147 | 244 | 210 | 423 | 341 | 590 | 567 | 532 | 643 | 602 |
| 159 | 208 | 287 | 726 | 830 | 1,494 | 1,529 | 1,784 | 202 | 1,288 | |
| Total Liabilities | 1,200 | 1,389 | 1,535 | 2,037 | 2,152 | 3,050 | 3,235 | 3,393 | 3,905 | 5,276 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 603 | 649 | 652 | 644 | 904 | 1,021 | 1,097 | 1,191 | 1,397 | 1,456 | |
| Capital Work in Progress | 0 | 0 | 0 | 57 | 17 | 31 | 103 | 195 | 160 | 177 |
| 0 | 12 | 9 | 6 | 20 | 0 | 0 | 0 | 0 | 0 | |
| 244 | 295 | 268 | 398 | 430 | 722 | 730 | 630 | 681 | 756 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 834 | 770 | 797 | |
| Cash & Bank | 7 | 18 | 21 | 147 | 68 | 103 | 150 | 277 | 576 | 1,681 |
| 346 | 415 | 585 | 784 | 714 | 1,173 | 1,155 | 266 | 321 | 411 | |
| Total Assets | 1,200 | 1,389 | 1,535 | 2,037 | 2,152 | 3,050 | 3,235 | 3,393 | 3,905 | 5,276 |
| Total Debt | 195 | 173 | 269 | 175 | 97 | 358 | 537 | 492 | 14 | 73 |
| Net Working Capital | 157 | 221 | 308 | 520 | 577 | 592 | 613 | 730 | 1,381 | 2,465 |
| Contingent Liabilities | 13 | 25 | 27 | 20 | 22 | 98 | 82 | 89 | 92 | 99 |
| Book Value per Share | 6052.59 | 6763.46 | 7285.81 | 5554.34 | 6801.28 | 86.95 | 50.13 | 49.59 | 199.01 | 216.41 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Total Debt | 195 | 173 | 269 | 175 | 97 | 358 | 537 | 492 | 14 | 73 |
| Net Working Capital | 157 | 221 | 308 | 520 | 577 | 592 | 613 | 730 | 1,381 | 2,465 |
| Contingent Liabilities | 13 | 25 | 27 | 20 | 22 | 98 | 82 | 89 | 92 | 99 |
| Book Value per Share | 6052.59 | 6763.46 | 7285.81 | 5554.34 | 6801.28 | 86.95 | 50.13 | 49.59 | 199.01 | 216.41 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Mar 2017
- Equity Capital
- 1
- 710
- 183
- Trade Payables
- 147
- 159
- Total Liabilities
- 1,200
- 603
- Capital Work in Progress
- 0
- 0
- 244
- 0
- Cash & Bank
- 7
- 346
- Total Assets
- 1,200
- Total Debt
- 195
- Net Working Capital
- 157
- Contingent Liabilities
- 13
- Book Value per Share
- 6052.59
- Face Value
- 10.00
- Total Debt
- 195
- Net Working Capital
- 157
- Contingent Liabilities
- 13
- Book Value per Share
- 6052.59
- Face Value
- 10.00
Mar 2018
- Equity Capital
- 1
- 794
- 143
- Trade Payables
- 244
- 208
- Total Liabilities
- 1,389
- 649
- Capital Work in Progress
- 0
- 12
- 295
- 0
- Cash & Bank
- 18
- 415
- Total Assets
- 1,389
- Total Debt
- 173
- Net Working Capital
- 221
- Contingent Liabilities
- 25
- Book Value per Share
- 6763.46
- Face Value
- 10.00
- Total Debt
- 173
- Net Working Capital
- 221
- Contingent Liabilities
- 25
- Book Value per Share
- 6763.46
- Face Value
- 10.00
Mar 2019
- Equity Capital
- 1
- 855
- 182
- Trade Payables
- 210
- 287
- Total Liabilities
- 1,535
- 652
- Capital Work in Progress
- 0
- 9
- 268
- 0
- Cash & Bank
- 21
- 585
- Total Assets
- 1,535
- Total Debt
- 269
- Net Working Capital
- 308
- Contingent Liabilities
- 27
- Book Value per Share
- 7285.81
- Face Value
- 10.00
- Total Debt
- 269
- Net Working Capital
- 308
- Contingent Liabilities
- 27
- Book Value per Share
- 7285.81
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 1
- 721
- 165
- Trade Payables
- 423
- 726
- Total Liabilities
- 2,037
- 644
- Capital Work in Progress
- 57
- 6
- 398
- 0
- Cash & Bank
- 147
- 784
- Total Assets
- 2,037
- Total Debt
- 175
- Net Working Capital
- 520
- Contingent Liabilities
- 20
- Book Value per Share
- 5554.34
- Face Value
- 10.00
- Total Debt
- 175
- Net Working Capital
- 520
- Contingent Liabilities
- 20
- Book Value per Share
- 5554.34
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 1
- 884
- 96
- Trade Payables
- 341
- 830
- Total Liabilities
- 2,152
- 904
- Capital Work in Progress
- 17
- 20
- 430
- 0
- Cash & Bank
- 68
- 714
- Total Assets
- 2,152
- Total Debt
- 97
- Net Working Capital
- 577
- Contingent Liabilities
- 22
- Book Value per Share
- 6801.28
- Face Value
- 10.00
- Total Debt
- 97
- Net Working Capital
- 577
- Contingent Liabilities
- 22
- Book Value per Share
- 6801.28
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 14
- 608
- 345
- Trade Payables
- 590
- 1,494
- Total Liabilities
- 3,050
- 1,021
- Capital Work in Progress
- 31
- 0
- 722
- 0
- Cash & Bank
- 103
- 1,173
- Total Assets
- 3,050
- Total Debt
- 358
- Net Working Capital
- 592
- Contingent Liabilities
- 98
- Book Value per Share
- 86.95
- Face Value
- 2.00
- Total Debt
- 358
- Net Working Capital
- 592
- Contingent Liabilities
- 98
- Book Value per Share
- 86.95
- Face Value
- 2.00
Mar 2023
- Equity Capital
- 29
- 689
- 421
- Trade Payables
- 567
- 1,529
- Total Liabilities
- 3,235
- 1,097
- Capital Work in Progress
- 103
- 0
- 730
- 0
- Cash & Bank
- 150
- 1,155
- Total Assets
- 3,235
- Total Debt
- 537
- Net Working Capital
- 613
- Contingent Liabilities
- 82
- Book Value per Share
- 50.13
- Face Value
- 2.00
- Total Debt
- 537
- Net Working Capital
- 613
- Contingent Liabilities
- 82
- Book Value per Share
- 50.13
- Face Value
- 2.00
Mar 2024
- Equity Capital
- 29
- 681
- 368
- Trade Payables
- 532
- 1,784
- Total Liabilities
- 3,393
- 1,191
- Capital Work in Progress
- 195
- 0
- 630
- 834
- Cash & Bank
- 277
- 266
- Total Assets
- 3,393
- Total Debt
- 492
- Net Working Capital
- 730
- Contingent Liabilities
- 89
- Book Value per Share
- 49.59
- Face Value
- 2.00
- Total Debt
- 492
- Net Working Capital
- 730
- Contingent Liabilities
- 89
- Book Value per Share
- 49.59
- Face Value
- 2.00
Mar 2025
- Equity Capital
- 31
- 3,016
- 14
- Trade Payables
- 643
- 202
- Total Liabilities
- 3,905
- 1,397
- Capital Work in Progress
- 160
- 0
- 681
- 770
- Cash & Bank
- 576
- 321
- Total Assets
- 3,905
- Total Debt
- 14
- Net Working Capital
- 1,381
- Contingent Liabilities
- 92
- Book Value per Share
- 199.01
- Face Value
- 2.00
- Total Debt
- 14
- Net Working Capital
- 1,381
- Contingent Liabilities
- 92
- Book Value per Share
- 199.01
- Face Value
- 2.00
Mar 2026
- Equity Capital
- 31
- 3,283
- 73
- Trade Payables
- 602
- 1,288
- Total Liabilities
- 5,276
- 1,456
- Capital Work in Progress
- 177
- 0
- 756
- 797
- Cash & Bank
- 1,681
- 411
- Total Assets
- 5,276
- Total Debt
- 73
- Net Working Capital
- 2,465
- Contingent Liabilities
- 99
- Book Value per Share
- 216.41
- Face Value
- 2.00
- Total Debt
- 73
- Net Working Capital
- 2,465
- Contingent Liabilities
- 99
- Book Value per Share
- 216.41
- Face Value
- 2.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 156 | 157 | -23 | 28 | 134 | 32 | 177 | 498 | 465 | 1,181 | |
| Cash from Investing | -128 | -111 | -49 | -190 | -109 | -235 | -305 | -330 | -548 | -930 |
| Cash from Financing | -34 | -35 | 75 | 233 | -95 | 236 | 125 | -108 | 73 | 34 |
| -7 | 11 | 3 | 71 | -70 | 33 | -4 | 60 | -10 | 285 | |
| Free Cash Flow | 17 | 60 | -81 | -81 | -159 | -198 | -69 | 228 | 142 | 971 |
| OCF / Net Profit | 1.63 | 1.74 | -0.33 | 0.64 | 1.08 | -0.13 | 1.81 | 630.71 | 1.35 | 4.61 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -245 | -460 | -588 | -279 | -56 | 1,074 |
| OCF / Net Profit | 1.63 | 1.74 | -0.33 | 0.64 | 1.08 | -0.13 | 1.81 | 630.71 | 1.35 | 4.61 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -245 | -460 | -588 | -279 | -56 | 1,074 |
Mar 2017
- 156
- Cash from Investing
- -128
- Cash from Financing
- -34
- -7
- Free Cash Flow
- 17
- OCF / Net Profit
- 1.63
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.63
- Cumulative 5-Year FCF
- 0
Mar 2018
- 157
- Cash from Investing
- -111
- Cash from Financing
- -35
- 11
- Free Cash Flow
- 60
- OCF / Net Profit
- 1.74
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.74
- Cumulative 5-Year FCF
- 0
Mar 2019
- -23
- Cash from Investing
- -49
- Cash from Financing
- 75
- 3
- Free Cash Flow
- -81
- OCF / Net Profit
- -0.33
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.33
- Cumulative 5-Year FCF
- 0
Mar 2020
- 28
- Cash from Investing
- -190
- Cash from Financing
- 233
- 71
- Free Cash Flow
- -81
- OCF / Net Profit
- 0.64
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.64
- Cumulative 5-Year FCF
- 0
Mar 2021
- 134
- Cash from Investing
- -109
- Cash from Financing
- -95
- -70
- Free Cash Flow
- -159
- OCF / Net Profit
- 1.08
- Cumulative 5-Year FCF
- -245
- OCF / Net Profit
- 1.08
- Cumulative 5-Year FCF
- -245
Mar 2022
- 32
- Cash from Investing
- -235
- Cash from Financing
- 236
- 33
- Free Cash Flow
- -198
- OCF / Net Profit
- -0.13
- Cumulative 5-Year FCF
- -460
- OCF / Net Profit
- -0.13
- Cumulative 5-Year FCF
- -460
Mar 2023
- 177
- Cash from Investing
- -305
- Cash from Financing
- 125
- -4
- Free Cash Flow
- -69
- OCF / Net Profit
- 1.81
- Cumulative 5-Year FCF
- -588
- OCF / Net Profit
- 1.81
- Cumulative 5-Year FCF
- -588
Mar 2024
- 498
- Cash from Investing
- -330
- Cash from Financing
- -108
- 60
- Free Cash Flow
- 228
- OCF / Net Profit
- 630.71
- Cumulative 5-Year FCF
- -279
- OCF / Net Profit
- 630.71
- Cumulative 5-Year FCF
- -279
Mar 2025
- 465
- Cash from Investing
- -548
- Cash from Financing
- 73
- -10
- Free Cash Flow
- 142
- OCF / Net Profit
- 1.35
- Cumulative 5-Year FCF
- -56
- OCF / Net Profit
- 1.35
- Cumulative 5-Year FCF
- -56
Mar 2026
- 1,181
- Cash from Investing
- -930
- Cash from Financing
- 34
- 285
- Free Cash Flow
- 971
- OCF / Net Profit
- 4.61
- Cumulative 5-Year FCF
- 1,074
- OCF / Net Profit
- 4.61
- Cumulative 5-Year FCF
- 1,074
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 813.11 | 770.15 | 579.08 | 367.37 | 943.16 | -35.30 | 6.63 | -0.28 | 22.09 | 16.67 |
| Book Value (₹) | 6052.59 | 6763.46 | 7285.81 | 5554.34 | 6801.28 | 86.95 | 50.13 | 49.59 | 199.01 | 216.41 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 |
| Cash EPS (₹) | 10.93 | 10.99 | 9.59 | 7.71 | 13.51 | -10.92 | 14.72 | 8.84 | 32.48 | 26.84 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 10.94% | 13.77% | 10.18% | 8.35% | 11.47% | -1.88% | 10.51% | 2.94% | 11.18% | 11.98% |
| Net Margin % | 5.13% | 5.82% | 3.39% | 1.81% | 4.53% | -6.83% | 2.68% | 0.02% | 8.35% | 5.88% |
| ROE % | 14.25% | 12.02% | 8.24% | 5.53% | 15.36% | -33.30% | 14.61% | 0.11% | 18.30% | 8.06% |
| ROCE % | 18.08% | 17.35% | 14.20% | 13.23% | 19.05% | -18.00% | 17.59% | 0.43% | 17.83% | 14.77% |
| 8.10% | 6.99% | 4.65% | 2.44% | 5.89% | -9.64% | 3.11% | 0.02% | 9.42% | 5.59% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 54 | 74 | 73 | 80 | 75 | 70 | 86 | 73 | 71 | 66 |
| Inventory Days | 52 | 63 | 51 | 50 | 56 | 57 | 73 | 59 | 58 | 60 |
| Payable Days | 52 | 77 | 63 | 78 | 83 | 72 | 93 | 79 | 88 | 90 |
| 55 | 60 | 62 | 52 | 48 | 55 | 66 | 54 | 41 | 35 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.27x | 0.22x | 0.31x | 0.24x | 0.11x | 0.58x | 0.75x | 0.69x | 0.00x | 0.02x |
| Interest Coverage (x) | 10.19x | 12.66x | 6.59x | 6.71x | 26.54x | -10.60x | 4.25x | 0.11x | 10.98x | 5.06x |
| 1.38x | 1.46x | 1.59x | 1.71x | 2.00x | 1.46x | 1.48x | 1.60x | 2.54x | 3.25x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 12.49% | -16.41% | 29.37% | 20.21% | 12.78% | 34.87% | -0.46% | 14.32% | -1.44% | 5.85% |
| Operating Profit Growth % | 36.48% | 5.05% | -4.50% | -1.40% | 54.92% | -122.12% | 655.88% | -59.12% | 229.02% | 25.97% |
| Net Profit Growth % | 114.53% | -5.28% | -24.81% | -35.84% | 182.76% | -303.24% | 138.99% | -99.19% | 0.00% | -25.42% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -104.25% | 7932.55% | -24.54% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 21.49x | 27.96x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 2.38x | 2.15x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.64% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 1.55x | 12.98x | 8.49x |
Mar 2017
- EPS (₹)
- 813.11
- Book Value (₹)
- 6052.59
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 10.93
- Operating Margin %
- 10.94%
- Net Margin %
- 5.13%
- ROE %
- 14.25%
- ROCE %
- 18.08%
- 8.10%
- Debtor Days
- 54
- Inventory Days
- 52
- Payable Days
- 52
- 55
- Debt to Equity (x)
- 0.27x
- Interest Coverage (x)
- 10.19x
- 1.38x
- Revenue Growth %
- 12.49%
- Operating Profit Growth %
- 36.48%
- Net Profit Growth %
- 114.53%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 770.15
- Book Value (₹)
- 6763.46
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 10.99
- Operating Margin %
- 13.77%
- Net Margin %
- 5.82%
- ROE %
- 12.02%
- ROCE %
- 17.35%
- 6.99%
- Debtor Days
- 74
- Inventory Days
- 63
- Payable Days
- 77
- 60
- Debt to Equity (x)
- 0.22x
- Interest Coverage (x)
- 12.66x
- 1.46x
- Revenue Growth %
- -16.41%
- Operating Profit Growth %
- 5.05%
- Net Profit Growth %
- -5.28%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 579.08
- Book Value (₹)
- 7285.81
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 9.59
- Operating Margin %
- 10.18%
- Net Margin %
- 3.39%
- ROE %
- 8.24%
- ROCE %
- 14.20%
- 4.65%
- Debtor Days
- 73
- Inventory Days
- 51
- Payable Days
- 63
- 62
- Debt to Equity (x)
- 0.31x
- Interest Coverage (x)
- 6.59x
- 1.59x
- Revenue Growth %
- 29.37%
- Operating Profit Growth %
- -4.50%
- Net Profit Growth %
- -24.81%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 367.37
- Book Value (₹)
- 5554.34
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 7.71
- Operating Margin %
- 8.35%
- Net Margin %
- 1.81%
- ROE %
- 5.53%
- ROCE %
- 13.23%
- 2.44%
- Debtor Days
- 80
- Inventory Days
- 50
- Payable Days
- 78
- 52
- Debt to Equity (x)
- 0.24x
- Interest Coverage (x)
- 6.71x
- 1.71x
- Revenue Growth %
- 20.21%
- Operating Profit Growth %
- -1.40%
- Net Profit Growth %
- -35.84%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 943.16
- Book Value (₹)
- 6801.28
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 13.51
- Operating Margin %
- 11.47%
- Net Margin %
- 4.53%
- ROE %
- 15.36%
- ROCE %
- 19.05%
- 5.89%
- Debtor Days
- 75
- Inventory Days
- 56
- Payable Days
- 83
- 48
- Debt to Equity (x)
- 0.11x
- Interest Coverage (x)
- 26.54x
- 2.00x
- Revenue Growth %
- 12.78%
- Operating Profit Growth %
- 54.92%
- Net Profit Growth %
- 182.76%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- -35.30
- Book Value (₹)
- 86.95
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -10.92
- Operating Margin %
- -1.88%
- Net Margin %
- -6.83%
- ROE %
- -33.30%
- ROCE %
- -18.00%
- -9.64%
- Debtor Days
- 70
- Inventory Days
- 57
- Payable Days
- 72
- 55
- Debt to Equity (x)
- 0.58x
- Interest Coverage (x)
- -10.60x
- 1.46x
- Revenue Growth %
- 34.87%
- Operating Profit Growth %
- -122.12%
- Net Profit Growth %
- -303.24%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 6.63
- Book Value (₹)
- 50.13
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 14.72
- Operating Margin %
- 10.51%
- Net Margin %
- 2.68%
- ROE %
- 14.61%
- ROCE %
- 17.59%
- 3.11%
- Debtor Days
- 86
- Inventory Days
- 73
- Payable Days
- 93
- 66
- Debt to Equity (x)
- 0.75x
- Interest Coverage (x)
- 4.25x
- 1.48x
- Revenue Growth %
- -0.46%
- Operating Profit Growth %
- 655.88%
- Net Profit Growth %
- 138.99%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- -0.28
- Book Value (₹)
- 49.59
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 8.84
- Operating Margin %
- 2.94%
- Net Margin %
- 0.02%
- ROE %
- 0.11%
- ROCE %
- 0.43%
- 0.02%
- Debtor Days
- 73
- Inventory Days
- 59
- Payable Days
- 79
- 54
- Debt to Equity (x)
- 0.69x
- Interest Coverage (x)
- 0.11x
- 1.60x
- Revenue Growth %
- 14.32%
- Operating Profit Growth %
- -59.12%
- Net Profit Growth %
- -99.19%
- -104.25%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 1.55x
Mar 2025
- EPS (₹)
- 22.09
- Book Value (₹)
- 199.01
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 32.48
- Operating Margin %
- 11.18%
- Net Margin %
- 8.35%
- ROE %
- 18.30%
- ROCE %
- 17.83%
- 9.42%
- Debtor Days
- 71
- Inventory Days
- 58
- Payable Days
- 88
- 41
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 10.98x
- 2.54x
- Revenue Growth %
- -1.44%
- Operating Profit Growth %
- 229.02%
- Net Profit Growth %
- 0.00%
- 7932.55%
- P/E (x)
- 21.49x
- P/B (x)
- 2.38x
- Dividend Yield %
- 0.00%
- 12.98x
Mar 2026
- EPS (₹)
- 16.67
- Book Value (₹)
- 216.41
- Dividend per Share (₹)
- 3.00
- Cash EPS (₹)
- 26.84
- Operating Margin %
- 11.98%
- Net Margin %
- 5.88%
- ROE %
- 8.06%
- ROCE %
- 14.77%
- 5.59%
- Debtor Days
- 66
- Inventory Days
- 60
- Payable Days
- 90
- 35
- Debt to Equity (x)
- 0.02x
- Interest Coverage (x)
- 5.06x
- 3.25x
- Revenue Growth %
- 5.85%
- Operating Profit Growth %
- 25.97%
- Net Profit Growth %
- -25.42%
- -24.54%
- P/E (x)
- 27.96x
- P/B (x)
- 2.15x
- Dividend Yield %
- 0.64%
- 8.49x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-13 - Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Schedule of meet
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-13 - Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Transcript
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Aug 2026
May 2026
Feb 2026